Management of Recurrence of Symptoms of Gastroesophageal Reflux Disease: Synergistic Effect of Rebamipide with 15 mg Lansoprazole
- 3 March 2010
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (12) , 3393-3398
Abstract
Proton pump inhibitors (PPIs) are effective in healing reflux esophagitis and relieving the symptoms of gastroesophageal reflux disease (GERD). Prevention of recurrence of symptoms has become a therapeutic aim in patients with these conditions.Keywords
This publication has 42 references indexed in Scilit:
- Inflammation and Oxidative Stress in Gastroesophageal Reflux DiseaseJournal of Clinical Biochemistry and Nutrition, 2007
- Prevention by Rebamipide of Acute Reflux Esophagitis in RatsDigestive Diseases and Sciences, 2005
- 15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New ApplicationsDigestive Diseases and Sciences, 2005
- Interleukin‐8 expression in the esophageal mucosa of patients with gastroesophageal reflux diseaseScandinavian Journal of Gastroenterology, 2004
- Effect of Rebamipide on Acetic Acid-induced Gastric Ulcer in Rats: Involvement of Hepatocyte Growth FactorScandinavian Journal of Gastroenterology, 2003
- Treatment of mild and severe cases of GERDAlimentary Pharmacology & Therapeutics, 2002
- LansoprazoleDrugs, 2001
- Rebamipide protects against activation of neutrophils byHelicobacter pyloriDigestive Diseases and Sciences, 1996
- Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus.Gut, 1995
- Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in ratsDigestive Diseases and Sciences, 1993